Texas Instruments Incorporated
$256.21B- Market cap
- $245.39B
- Debt
- +$14.05B
- Cash
- −$3.23B
Capital structure 95% equity / 5% debt · EV / Revenue 14.49x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $245.39B · View financials
Snapshot Sep 11, 2026, 4:00 PM ET
Decision snapshot: TXN stock price vs WAT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WAT's multiple
Needs WAT P/E.
Implied fair value · at TXN's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 95% equity / 5% debt · EV / Revenue 14.49x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TEXAS INSTRUMENTS INCORPORATED · implied price per share
Bear
$24.46
Base
$29.37
Bull
$38.11
Waters Corporation · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Intel Corporation
TXN vs INTC
QUALCOMM Incorporated
TXN vs QCOM
NVIDIA Corporation
TXN vs NVDA
Broadcom Inc.
TXN vs AVGO
DANAHER CORP /DE/
TXN vs DHR
AGILENT TECHNOLOGIES, INC.
TXN vs A
BIO-RAD LABORATORIES, INC.
TXN vs BIO
THERMO FISHER SCIENTIFIC INC.
TXN vs TMO
BRUKER CORP
TXN vs BRKR
BIO-TECHNE Corp
TXN vs TECH
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TXN can sustain its 13.0% revenue growth and premium margins without multiple compression, then hold or accumulate only on weakness because the current price already reflects a rich quality premium versus WAT.
TXN trades at a discount to WAT-implied price range only on the P/E-based framework if one accepts the implied price of $200.02, but that still leaves the stock well below its current $281.36 quote. Relative to WAT, TXN carries richer absolute multiples on P/E, P/S, and EV/Revenue, while EV/EBITDA is the lone metric where TXN looks cheaper.
Supporting Metrics